Roivant subsidiary Dermavant Sciences signs agreement with GSK to purchase rights to tapinarof Read more
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Read more
BioCryst Pharmaceuticals Announces Termination of Merger Agreement with Idera Pharmaceuticals Read more
Juniper Pharma Signs Definitive Agreement to be Acquired by Catalent for $11.50 Per Share in Cash Read more